These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7561215)

  • 21. [Intravitreal injection of ganciclovir in AIDS patients with cytomegalovirus retinitis].
    Fujino Y; Nagata Y; Miyoshi M; Ono A; Oka S; Iwamoto A; Kimura S; Mochizuki M
    Nippon Ganka Gakkai Zasshi; 1996 Aug; 100(8):634-40. PubMed ID: 8810241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravitreal ganciclovir for cytomegalovirus retinitis in patients with AIDS.
    Montero MC; Pastor M; Buenestado C; Lluch A; Atienza M
    Ann Pharmacother; 1996; 30(7-8):717-23. PubMed ID: 8826547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.
    Martin DF; Sierra-Madero J; Walmsley S; Wolitz RA; Macey K; Georgiou P; Robinson CA; Stempien MJ;
    N Engl J Med; 2002 Apr; 346(15):1119-26. PubMed ID: 11948271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir.
    Drew WL; Stempien MJ; Andrews J; Shadman A; Tan SJ; Miner R; Buhles W
    J Infect Dis; 1999 Jun; 179(6):1352-5. PubMed ID: 10228054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis.
    Ussery FM; Gibson SR; Conklin RH; Piot DF; Stool EW; Conklin AJ
    Ophthalmology; 1988 May; 95(5):640-8. PubMed ID: 2845321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.
    Boss JD; Rosenberg K; Shah R
    J Pediatr Ophthalmol Strabismus; 2016 Oct; 53():e58-e60. PubMed ID: 27783090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management of cytomegalovirus disease in patients with AIDS.
    Jacobson MA
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A sensitive and specific polymerase chain reaction-based assay for the diagnosis of cytomegalovirus retinitis.
    McCann JD; Margolis TP; Wong MG; Kuppermann BD; Luckie AP; Schwartz DM; Irvine AR; Ai E
    Am J Ophthalmol; 1995 Aug; 120(2):219-26. PubMed ID: 7639306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ganciclovir implants: one year later.
    Cadman J
    GMHC Treat Issues; 1997; 11(4/5):3-6. PubMed ID: 11364375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis.
    Piketty C; Bardin C; Gilquin J; Gairard A; Kazatchkine MD; Chast F
    Clin Microbiol Infect; 2000 Mar; 6(3):117-20. PubMed ID: 11168085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS.
    Vitravene Study Group
    Am J Ophthalmol; 2002 Apr; 133(4):467-74. PubMed ID: 11931780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis.
    Sastry SM; Epps CH; Walton RC; Rana SN; Sanders RJ
    J Natl Med Assoc; 1996 Oct; 88(10):661-2. PubMed ID: 8918073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.
    Jacobson MA; Drew WL; Feinberg J; O'Donnell JJ; Whitmore PV; Miner RD; Parenti D
    J Infect Dis; 1991 Jun; 163(6):1348-51. PubMed ID: 1645385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA
    Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
    Plosker GL; Noble S
    Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
    Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
    Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-weekly intraocular injections of ganciclovir for maintenance therapy of cytomegalovirus retinitis: clinical and ocular outcome.
    Hodge WG; Lalonde RG; Sampalis J; Deschênes J
    J Infect Dis; 1996 Aug; 174(2):393-6. PubMed ID: 8699072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome.
    Díaz-Llopis M; Chipont E; Sanchez S; España E; Navea A; Menezo JL
    Am J Ophthalmol; 1992 Dec; 114(6):742-7. PubMed ID: 1334376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis.
    Weinberg DV; Murphy R; Naughton K
    Am J Ophthalmol; 1994 Jun; 117(6):776-82. PubMed ID: 8198162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.